期刊论文详细信息
Cellular Physiology and Biochemistry
The Cholinergic Antagonist Gymnodimine Improves Aβ and Tau Neuropathology in an in Vitro Model of Alzheimer Disease
关键词: Gymnodimine;    Alzheimer disease;    Tau protein;    Beta-amyloid;    Acetylcholine;   
DOI  :  10.1159/000330086
学科分类:分子生物学,细胞生物学和基因
来源: S Karger AG
PDF
【 摘 要 】

Gymnodimine (GYM) is a marine phycotoxin with a macrocyclic imine structure, isolated from extracts of the dinoflagellate Karenia selliformis known to act as a cholinergic antagonist with subtype selectivity. However, no data on the chronic effects of this compound has been reported so far. In this work, we evaluated the effect of long term exposure of cortical neurons to gymnodimine in the progress of Alzheimer disease (AD) pathology in vitro. Treatment of cortical neurons with 50 nM gymnodimine decreased the intracellular amyloid beta (Aβ) accumulation and the levels of the hyperphosphorylated isoforms of tau protein recognized by AT8 and AT100 antibodies. These results are suggested to be mediated by the increase in the inactive isoform of the glycogen synthase kinase-3 (phospho GSK-3 Ser9), the decrease in the levels of the active isoform of the ERK1/2 kinase and the increase in acetylcholine (Ach) synthesis elicited by long term exposure of cortical neurons to the toxin. Moreover, gymnodimine decreased glutamate-induced neurotoxicity in vitro. Altogether these results indicate that the marine phycotoxin gymnodimine may constitute a valuable tool for the development of drugs to treat neurodegenerative diseases.

【 授权许可】

CC BY-NC-ND   

【 预 览 】
附件列表
Files Size Format View
RO201904038038327ZK.pdf 988KB PDF download
  文献评价指标  
  下载次数:30次 浏览次数:13次